Evidence mapPaperPMID 40467768Full record

SynthesisScientific reports2025

Identification of key proteins and pathways in myocardial infarction using machine learning approaches.

Chang Liu, Xing Zhang, Qian Xie, Binbin Fang, Fen Liu, Junyi Luo, Gulandanmu Aihemaiti, Wei Ji, Yining Yang, Xiaomei Li

Abstract readMeta-Analysis
In one paragraph

Synthesis in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Potential ofFrontiers in immunology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chang Liu *Department of Cardiology, The first Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
Xing Zhang *Department of Cardiology, The first Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
Qian Xie *Department of Cardiology, The first Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
Binbin Fang *Department of Cardiology, The first Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
Fen LiuDepartment of Cardiology, The first Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
Junyi LuoDepartment of Cardiology, The first Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
Gulandanmu AihemaitiDepartment of Cardiology, The first Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
Wei JiDepartment of Cardiology, The first Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China.
Yining YangDepartment of Cardiology, People's Hospital of Xinjiang Uyghur Autonomous Region, Urumqi, 830001, China. yangyn5126@163.com.
Xiaomei LiDepartment of Cardiology, The first Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China. lixm505@163.com.

Funding

National Natural Science Foundation of China 8216020109Special Fund Project for Central Guidance of Local Science and Technology Development ZYYD2022C21the Key Research and Development Task Special in Xinjiang Uygur Autonomous Region 2022B03022-2"Tianshan Talents" High-Level Talent Training Program in Medicine and Healthcare 2022TSYCCX0033"Tianshan Talents" High-Level Talent Training Program in Medicine and Healthcare 2022TSYCLJ0028"Tianshan Talents" High-Level Talent Training Program in Medicine and Healthcare 2023TSYCLJ0035
6 · The paper itself

Abstract

Acute myocardial infarction (AMI) is a leading cause of global morbidity and mortality, requiring deeper insights into its molecular mechanisms for improved diagnosis and treatment. This study combines proteomics, transcriptomics and machine learning (ML) to identify key proteins and pathways associated with AMI. Plasma samples from 48 AMI patients and 50 healthy controls (HC) were used for proteomic sequencing. Differentially expressed proteins (DEPs) were identified and analyzed for pathway enrichment. Protein-protein interaction (PPI) networks were constructed, and we conducted a meta-analysis (GSE60993, GSE61144, GSE48060) using an inverse variance model to combine differentially expressed genes (DEGs) identified via LIMMA and FDR adjustment across three studies. Clustering and co-expression analysis were performed using K-Medoids and weighted gene co-expression network analysis (WGCNA). ML feature selection identified hub proteins, which were validated across bulk, single-cell, and spatial datasets for atherosclerosis (ATH) and MI. In this study, we identified 437 DEPs with 291 up-regulated and 146 down-regulated proteins. Functional enrichment analysis revealed key pathways involved in inflammation, immunity, metabolism, and cellular stress responses, among others. Using non-negative matrix factorization (NNMF) and K-Medoids clustering, AMI patients were divided into two clusters (C1 and C2), with distinct protein expression patterns and inflammatory responses. Differential analysis between clusters revealed 200 cluster-specific DEPs, with C1 associated with angiogenesis and vascular remodeling, and C2 linked to cellular stress and apoptosis. A meta-analysis identified 1383 DEGs, and their intersection with DEPs yielded 63 proteins, which were subsequently refined by logistic regression to 36 AMI-associated proteins. Furthermore, a protein co-expression network analysis identified 49 modules, with the turquoise module being strongly associated with AMI highlighting pathways in lipid metabolism, immune response, and tissue repair. From this module, 17 key proteins were selected, and ML further distilled these to nine core features (CAMP, CLTC, CTNNB1, FUBP3, IQGAP1, MANBA, ORM1, PSME1, and SPP1) that are closely linked to immune regulation, apoptosis, and metabolism. These proteins were validated across multiple datasets. Single-cell analysis revealed distinct expression patterns of these proteins across cell types and spatial regions in ATH and MI, emphasizing their roles in inflammation, vascular remodeling, and plaque instability. This study identifies critical proteins and pathways in AMI, offering potential biomarkers and therapeutic targets. The use of ML provides a robust framework for identifying AMI's key molecular.

Indexed as

Machine LearningMyocardial InfarctionFemaleGene Expression ProfilingGene Regulatory NetworksHumansMaleMiddle AgedProtein Interaction MapsProteomicsSignal TransductionTranscriptomeAcute myocardial infarctionFunctional enrichment analysisMachine learningProteomicsSingle-cell sequencing

Identifiers

PMID40467768
PMCPMC12137932

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.